Sanofi Pasteur MET59

Mar 3, 2021

Started: 9/2019

Study Name: Immunogenicity and Safety of a Booster Dose of an Investigational xxx Meningococcal Conjugate Vaccine in Adolescents and Adults

Indication: Meningitis

Principal Investigators: Paul Bernhardson, Brad Brabec, Steve Russell

This study is no longer active

Current Studies

C4931002

25-Valent Pneumococcal Conjugate Vaccine in Healthy Infants Given 4 Doses at 2,

Read More

V116-013

Phase 3 Study of Pneumococcal Vaccine in Children and adolescents with increased

Read More